Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for pulmonary nodules. Matrix Analytics has already developed technology for the management of pulmonary nodules. This technology, leveraged with cloud computing and deep learning, will begin clinical validation later this month. The new tool applies an automated cancer classifier identified in conventional chest computed tomography (CT) images to LungDirect's advanced learning algorithms.

September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALCON ...

September 12, 2017 — Fujifilm Medical Systems U.S.A. Inc. announced it has earned a new 10-year contract with a maximum ...

September 12, 2017 — The American Society of Radiologic Technologists (ASRT) announced it will donate $10,000 to the ...

Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens Somatom Force computed tomography (CT) scanner. The Somatom Force allows radiologists to obtain higher-quality images faster, more efficiently and with less radiation than older-generation CT scanners.

Sigmascreening recently announced that a study of in total 15,898 in digital mammograms from 3,772 Asian women underlines the need for compression guidelines. The study confirms a number of other studies indicating that a force-standardized protocol leads to large variations in compression practices. This has serious negative effects on patient experience and the efficacy of mammography. Therefore, pressure-guided mammography with the Sigma Paddle, which is taking breast size into account, may lead to improved test results and less unnecessary discomfort and pain especially for Asian women.

Konica Minolta will highlight its Exa Enterprise Imaging platform at the 2017 annual meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago.

Augmenix Inc. announced that the National Institute for Health and Care Excellence (NICE) in the U.K. has issued Interventional Procedure Guidance (IPG) supporting the use of a hydrogel barrier to reduce the risk of toxicity to surrounding tissue in radiotherapy to treat prostate cancer. The guidance recommends use of hydrogel spacers under "standard arrangements". For a procedure to be recommended for use with standard arrangements (previously called “normal arrangements”), the evidence should be adequate to show safety and efficacy of the procedure both in the long term and short term. NICE’s guidance clearly indicates that this procedure meets the highest evidence standards.

September 8, 2017 — Delphinus Medical Technologies Inc. announced that the SoftVue Discover Breast Ultrasound ...